Association of protein tyrosine phosphatase nonreceptor 22 (PTPN22) C1858t gene polymorphism with susceptibility to autoimmune thyroid diseases: A meta-analysis

Endocrine Journal

Volumn 59, Issue 5, 2012, Pages 439-445

  Luo, Limei ^a   Cai, Bei ^a   Liu, Fei ^a   Hu, Xin ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Autoimmune thyroid diseases; Meta analysis; Polymorphism; Protein tyrosine phosphatase nonreceptor 22

Indexed keywords

DNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22; UNCLASSIFIED DRUG;

ADULT; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; JAPAN; MALE; META ANALYSIS; NOTE; POLAND; RUSSIAN FEDERATION; TUNISIA;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; THYROIDITIS, AUTOIMMUNE;

EID: 84861864327     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0381     Document Type: Note

References (29)

1. Tomer Y, Huber A (2009) The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32:231-239.
2. Jacobson EM, Tomer Y (2007) The genetic basis of thyroid autoimmunity. Thyroid 17:949-961.
3. Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ (2010) Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Clin Endocrinol (Oxf) 72:248-255.
4. Weetman AP (2009) The genetics of autoimmune thyroid disease. Horm Metab Res 41:421-425.
5. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang S Y, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330-337.
6. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, Nika K, Tautz L, Tasken K, Cucca F, Mustelin T, Bottini N (2005) Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 37:1317-1319.
7. Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K (2005) Sex-specifc association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 153:895-899.
8. Ban Y, Tozaki T, Taniyama M, Tomita M (2005) The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15:1115-1118.
9. Heward JM, Brand OJ, Barrett JC, Carr-Smith JD, Franklyn JA, Gough SC (2007) Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab 92:685-690.
10. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129.
11. Higgins JP, Thompson SG, Deeks JJ AD (2003) Measuring inconsistency in meta - analyses. BMJ 327:557-560.
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
14. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
15. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
16. Zheng RZ, Zhang SH, Li R, Wang ZH, Wang MR, Wan XL, Liang Song (2008) Study on the relationship between polymorphism of PTPN22 and Graves' disease of Han nationality in Chongqing area. J CQ Medica Univ 33:22-28 (In Chinese).
17. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89:5862-5865.
18. Chabchoub G, Teixiera EP, Maalej A, Ben Hamad M, Bahloul Z, Cornelis F, Ayadi H (2009) The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol 36:342-349.
19. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Savage AD, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RCJ, Gough SCL, Todd JA (2004) Replication of an association between the lymphoid tyrosine phos-phatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
20. Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R (2005) Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) 62:679-682.
21. Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ (2009) The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 19:143-148.
22. Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y(2008) Associations of protein tyrosine phosphatase nonrecep-tor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid 18:625-630.
23. Zhebrun D, Kudryashova Y, Babenko A, Maslyansky A, Kunitskaya N, Popcova D, Klushina A, Grineva E, Kostareva A, Shlyakhto E (2011) Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. Aging (Albany NY) 3:368-373.
24. Zheng R (2008) Gene-gene interactions of FcRL3, FcrIIB and PTPN22 for autoimmune thyroid disease. Doctoral Dissertation of CQ medica univ (In Chinese).
25. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP (2011) Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett 585:3689-3698.
26. Bottini N, Vang T, Cucca F, Mustelin T (2006) Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18:207-213.
27. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-anal-ysis. Rheumatology (Oxford) 46:49-56.
28. Saranac L, Zivanovic S, Bjelakovic B, Stamenkovic H, Novak M, Kamenov B (2011) Why is the thyroid so prone to autoimmune disease? Horm Res Paediatr 75:157-165.
29. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.